News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,147 signal articles · 104 in last 24h · 178,672 total before filter · latest 1h ago

104last 24h

3124last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1818 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: WSTSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Zacks90d agobullish

Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut

WST

Zacks90d agobullish

iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised

WST

Trefis93d agoneutral

Cisco Stock Is Finally Pricing In A New Growth Story

ANET CSCO DELL FTNT HPE PANW WST ^GSPC

Zacks93d agobearish

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

WST ^GSPC

Zacks93d agobullish

AMN Q2 Earnings Beat Estimates on Staffing and Search Growth, Stock Up

WST ^GSPC

Zacks93d agoneutral

DOCS Q1 Earnings Miss on Higher AI Costs, Revenues Beat, FY27 View Up

WST

Zacks94d agobearish

PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut

WST

Zacks94d agobullish

LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised

WST

Zacks94d agobullish

MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised

WST

Insider Monkey94d agoneutral

Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2

WST

Zacks95d agoneutral

Can Segment Strength Offset Headwinds for BD Stock Before Q3 Earnings?

WST

Zacks95d agoneutral

HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up

WST

Zacks95d agobullish

COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised

WST ^GSPC

Zacks95d agobearish

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

WST

Zacks96d agobullish

RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up

WST

Zacks96d agobullish

Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up

WST

Simply Wall St.98d agobullish

Is Stronger Q2 Results, Raised Outlook and Buybacks Altering The Investment Case For West Pharmaceutical Services (WST)?

WST

Simply Wall St.98d agoneutral

West Pharmaceutical Services (WST) Raised Guidance, Is The Upside Already Priced In?

WST

StockStory99d agoneutral

The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings Call

WST

StockStory99d agobullish

3 Reasons to Avoid WST and 1 Stock to Buy Instead

WST

StockStory100d agoneutral

3 Cash-Heavy Stocks We Approach with Caution

WST

Zacks100d agobullish

MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised

WST ^GSPC

Zacks100d agoneutral

Resmed's Q4 Earnings on Deck: What's in Store for the Stock?

WST

Zacks100d agobearish

SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery

WST

Zacks101d agobullish

BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract

WST ^GSPC

Zacks101d agobullish

Glaukos Q2 Earnings Beat Estimates on iDose TR Growth, Stock Up

WST

Zacks102d agobullish

GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market

WST

Zacks102d agoneutral

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

DVA WST

Zacks102d agoneutral

Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?

WST

Zacks103d agoneutral

STERIS' Q1 Earnings on Deck: What's in Store for the Stock?

WST